Recognizing the imaging spectrum of IGM is crucial to prevent misdiagnosis as breast cancer. While inflammatory breast cancer and IGM can share many common imaging features, there are distinct findings that favor one diagnosis over the other, as highlighted in this poster. Multimodal imaging, combined with clinical and histopathological correlation, is essential for accurate diagnosis, minimizing unnecessary invasive procedures, and guiding appropriate management.